Who we are
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.
CORPORATE & U.S. HEADQUARTERS
10 Hudson Yards
New York, NY 10001
For all specific application queries, please email the Intercept Practice to Policy® Health Awards Program administration team.